DoMore Diagnostics and Proscia: Collaboration holds the promise to reduce overtreatment with integrated AI-powered pathology workflows OSLO and PHILADELPHIA – August 30, 2023 – DoMore Diagnostics, a leader in deep learning precision...

Oslo, Norway - DoMore Diagnostics, a leader in cancer outcome prediction with pathology AI algorithms, today announced that it has achieved CE-IVD mark for the Histotype Px  Colorectal, a deep learning algorithm that predict patient outcome...